Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
Mohammad-Reza Sedghipour, Ali Mostafaei, Yousef TaghaviNikoukari Ophthalmology University Hospital, Tabriz University of Medical Sciences, Tabriz, IranBackground: The purpose of this study was to assess the effect of bevacizumab in maintaining intraocular pressure lowered by trabeculectomy in refrac...
Enregistré dans:
Auteurs principaux: | Sedghipour MR, Mostafaei A, Taghavi Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fa3dea984b954836aa23f9eb47322a3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
par: Mostafaei A
Publié: (2011) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
par: Saeed AM, et autres
Publié: (2014) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
par: Freiberg FJ, et autres
Publié: (2013) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
par: Marey HM, et autres
Publié: (2011) -
Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma
par: Christopher C Shen, et autres
Publié: (2011)